Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Reexamination Certificate
2006-08-22
2006-08-22
Epps-Ford, Janet L. (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
C424S001110, C424S001210, C424S450000
Reexamination Certificate
active
07094771
ABSTRACT:
A pharmaceutical composition for boron neutron capture therapy (BNCT), and in particular for BNCT on hepatoma is disclosed. The pharmaceutical composition contains a therapeutically effective amount of triphenylboroxin (phenylboronic anhydride) as a boron source and a pharmaceutically acceptable carrier, such as lipiodol.
REFERENCES:
patent: 3864380 (1975-02-01), King et al.
patent: 5641793 (1997-06-01), Bradbury
patent: 5861401 (1999-01-01), Bradbury
patent: 6083951 (2000-07-01), Bradbury
patent: 6117852 (2000-09-01), Chou
patent: 20020047292 (2002-02-01), None
Mishima et al. Treatment of malignant melanoma by single thermal neutron capture therpy with melanoma seeking 10-B compound. Lancet. Aug. 12, 1989, vol. 2(8659), pp. 388-389.
Hatanaka et al. International Journal of Radiation Oncology, Biology, Physics. vol. 28, pp. 1061-1066, 1994.
Gravel et al., Universal Solid-Phase Approach for the Immodiblization, Derivatization, and Resin-to-Resin Transfer Reactions of Boronic Acids. Journal of Organic Chemistry. Published on Web: Nov. 29, 2001, 2002, vol. 67, pp. 3-15.
Cited by Applicants in specification.
Hawthorne et al. Preparation of Tumor-Specific Boron Compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets. Journal of Medicinal Chemistry. May 1972, vol. 15, No. 5. pp. 449-452.
Yanagie et al. Applied Radiation and Isotopes 61, pp. 639-646, 2004.
Borkovec et al. J. Econ. Entomol. vol. 62(6), pp. 1472-1480, Dec. 1969.
Robinson et al. Acta Cryst. C52, pp. 2826-2830, 1996.
Mehta et al. Phar. Res, vol. 13, No. 3, pp. 344-351, 1996.
Minoru Suzuki et al., “The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice”, Oct. 2000, pp. 1058-1064, Jpn. J. Cancer Res. 91.
Carolyn Bratt Brock, Robin P. Minton and Kurt Niedenzu, “Structure and Thermal Motion of Tripheynlboroxin”, pp. 1775-1779, Acta Cryst. (1987). C43.
Barth, R.F., et al., “Boron Neutron Capture Therpay of Brain Tumors: Enhanced Survival and Cure Following Blood-Brain Barrier Disruption and Intracarotid Injection of sodium Borocaptate and Boronophenylalanine”, 2000. pp. 209-218, Int. J. Radiation Oncology Biol. Phys. vol. 47, No. 1.
Bacon & Thomas PLLC
Epps-Ford Janet L.
National Tsing Hua University
LandOfFree
Pharmaceutical composition for boron neutron capture therapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for boron neutron capture therapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for boron neutron capture therapy... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3668395